Trial Profile
A Study to Evaluate the Safety, Tolerability, and Absolute Bioavailability of Subcutaneous LY2189265.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Dulaglutide (Primary) ; Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 18 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.